Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer
作 者 详细资料
相关链接
DOI URL
阿平 的文献笔记 订阅 |
复发性卵巢癌
免疫治疗+抗血管 治疗在铂类药物敏感的病人中有效率高达40%，而在铂类化疗不敏感者只有16%，看来有潜力可挖。 |
A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profilingOncogenic Signaling Alters Cell Shape and Mechanics to Facilitate Cell Division under Confinement
浙公网安备 33010202000686号 ( 浙ICP备09035230号-1 )
